Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014 - WDAM - TV 7 - News, Weather and Sports

Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, June 26, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014

http://www.reportlinker.com/p02133107/Glucocorticoid-Induced-Osteoporosis-Global-Clinical-Trials-Review-H1-2014.html

Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014" provides data on the Glucocorticoid-Induced Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucocorticoid-Induced Osteoporosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glucocorticoid-Induced Osteoporosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Glucocorticoid-Induced Osteoporosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Glucocorticoid-Induced Osteoporosis to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Glucocorticoid-Induced Osteoporosis to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Glucocorticoid-Induced Osteoporosis 23
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Glucocorticoid-Induced Osteoporosis 30
May 29, 2013: Lilly's Forteo Significantly Increases Bone Mineral Density In Men With Glucocorticoid-Induced Osteoporosis 30
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
F. Hoffmann-La Roche Ltd. 32
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 32
Eli Lilly and Company 33
Clinical Trial Overview of Eli Lilly and Company 33
Novartis India Limited 34
Clinical Trial Overview of Novartis India Limited 34
Bluefish Pharmaceuticals AB 35
Clinical Trial Overview of Bluefish Pharmaceuticals AB 35
Amgen Inc. 36
Clinical Trial Overview of Amgen Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
Shinko Hospital 37
Clinical Trial Overview of Shinko Hospital 37
Osaka University 38
Clinical Trial Overview of Osaka University 38
Society for glucocorticoid-induced osteoporosis 39
Clinical Trial Overview of Society for glucocorticoid-induced osteoporosis 39
Keio University 40
Clinical Trial Overview of Keio University 40
Nihon University 41
Clinical Trial Overview of Nihon University 41
Boston Children's Hospital 42
Clinical Trial Overview of Boston Children's Hospital 42
The University of Tokyo 43
Clinical Trial Overview of The University of Tokyo 43
Kinki University 44
Clinical Trial Overview of Kinki University 44
The National Institute of Diabetes and Digestive and Kidney Diseases 45
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 45
UMC Utrecht Holding BV 46
Clinical Trial Overview of UMC Utrecht Holding BV 46
Five Key Clinical Profiles 47
Appendix 93
Abbreviations 93
Definitions 93
Research Methodology 94
Secondary Research 94
About GlobalData 95
Contact Us 95
Disclaimer 95
Source 95

List of Tables
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Glucocorticoid-Induced Osteoporosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Glucocorticoid-Induced Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Glucocorticoid-Induced Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Glucocorticoid-Induced Osteoporosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Glucocorticoid-Induced Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Glucocorticoid-Induced Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 23
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Glucocorticoid-Induced Osteoporosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 32
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 33
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis India Limited, 2014* 34
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 35
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 36
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shinko Hospital, 2014* 37
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 38
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Society for glucocorticoid-induced osteoporosis, 2014* 39
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2014* 40
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon University, 2014* 41
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014* 42
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2014* 43
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kinki University, 2014* 44
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 45
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 46

List of Figures
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Glucocorticoid-Induced Osteoporosis to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Glucocorticoid-Induced Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Glucocorticoid-Induced Osteoporosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Glucocorticoid-Induced Osteoporosis to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Glucocorticoid-Induced Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Glucocorticoid-Induced Osteoporosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Glucocorticoid-Induced Osteoporosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Glucocorticoid-Induced Osteoporosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Glucocorticoid-Induced Osteoporosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 94

Companies Mentioned

To order this report: Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p02133107/Glucocorticoid-Induced-Osteoporosis-Global-Clinical-Trials-Review-H1-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.